GHMP yields 363636.36% · ABBV yields 3.06%● Live data
📍 GHMP pulled ahead of the other in Year 1
Combined, GHMP + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GHMP + ABBV for your $10,000?
Good Hemp, Inc. operates in the hemp and beverage industries in the United States. The company offers Good Hemp 2oh!, CANNA HEMP, and CANNA that are refreshing ready-to-drink waters in blueberry-blast, island coco-lime, kiwi-strawberry, lemon-twist, mango-fandango, and Q-cumbermint flavors; Good Hemp fizz, a line-up of carbonated refreshing ready-to-drink carbonated beverages in blueberry-bam, mango-tango, and citrus-twist flavors; Good Hemp Wellness, a line of CBD soft gels; and Diamond Creek High Alkaline Water, a 9.5pH high alkaline natural spring water. It distributes its products through direct store delivery and direct to retail channels, as well as direct to consumer through Amazon.com and Goodhemplivin.com. The company was formerly known as Lone Star Gold, Inc. and changed its name to Good Hemp, Inc. in September 2019. Good Hemp, Inc. was incorporated in 2007 and is based in Cornelius, North Carolina.
Full GHMP Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.